Sector VYNE Therapeutics Inc.

Equities

VYNE

US92941V3087

Biotechnology & Medical Research

Real-time Estimate Cboe BZX 03:08:49 2025-02-10 pm EST 5-day change 1st Jan Change
2.290 USD -4.98% Intraday chart for VYNE Therapeutics Inc. -1.72% -31.94%
Main competitors
Add to a list
Change 5d. change 1 months change 3 months change 1st Jan change 1-year change 3-years change 5-years change 10-years change Capi.($)
-4.98%-1.72%-33.53%-24.50%-31.94%+10.14%-77.60% - - 35.55M
-0.19%-0.55%+14.21%-6.77%+16.16%+11.77%+98.30%+91.12%+331.40% 121B
-1.62%+4.66%+0.24%-15.40%-1.94%-26.24%+12.99%+80.87%+74.32% 75.99B
+0.22%-0.28%-1.65%+13.31%+5.57%+74.78%+144.37%+338.95%+7,887.39% 39.71B
-1.41%-3.20%-5.58%+6.68%+1.79%+23.58%-30.77%+261.11% - 28.2B
-1.67%-1.51%+24.61%+7.39%+19.21%+50.23%+0.15%+32.06% - 23.85B
+0.74%+5.85%+11.39%+4.42%+6.47%+10.32%-36.81%-3.84% - 22.87B
+1.72%+2.75%+15.01%-5.70%+15.05%+339.61%+833.18%+1,151.83% - 14.83B
-2.22%+0.56%+20.02%+9.04%+13.43%+181.70%+233.96%+142.00%+385.81% 14.3B
-4.53%-22.36%-17.29%-8.36%-14.62%-10.65%+46.41%+9.95%+225.26% 12.41B
-1.26%-1.87%-14.93%-15.01%-8.38%-28.33%-38.98%-16.87%+187.29% 12.19B
+2.35%+18.35%+28.84%+27.34%+24.15%+25.87%-64.61%-39.56% - 11.2B
-2.09%+0.87%+5.51%-17.45%+4.51%+11.96%+327.96% - - 10.9B
+1.57%-0.15%-8.94%-3.56%-6.54%-10.74%+44.40%-8.15%+803.34% 10.68B
+1.03%+3.53%-5.50%-5.94%+2.22%+66.94%+79.82%+77.20%+1,454.34% 9.56B
+0.74%-.--%-.--%-.--%-.--%+4.85%+48.09% - - 8.19B
-0.62%+6.08%+14.25%-5.00%+6.34%+58.02%+228.33% - - 7.48B
+1.39%+3.32%-0.77%-0.99%+8.98%+55.45%+272.49%+269.91% - 7.26B
-0.54%-3.37%-6.44%-5.86%-12.20%-16.41%-2.14%-15.95%+561.58% 7.23B
-1.72%+1.20%-2.59%-18.40%+0.07%+47.63%+492.22%+177.95%+727.75% 7.13B
Average -0.65%-0.55%+1.84%-3.24%+2.42%+44.02%+130.59%+159.29%+1,263.85% 22.24B
Weighted average by Cap. -0.56%+0.70%+6.16%-3.22%+6.99%+30.79%+99.71%+145.86%+1,294.07%
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. VYNE Stock
  4. Sector VYNE Therapeutics Inc.